Annual report pursuant to Section 13 and 15(d)

Note 13 - Business Segments - Schedule of Segment Information (Details)

v3.22.2.2
Note 13 - Business Segments - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Net sales $ 484,859 $ 436,750
Operating income 31,781 32,711
Purchases of property, plant and equipment 12,378 5,586
Depreciation and amortization 15,032 13,754
Assets 523,681 434,288
Equity investment in joint venture 9,886 10,433
Operating Segments [Member]    
Operating income 46,232 45,749
Corporate, Non-Segment [Member]    
Assets 6,695 4,586
Delta Group [Member]    
Net sales 424,799 387,015
Delta Group [Member] | Operating Segments [Member]    
Net sales 424,799 387,015
Operating income [1] 38,045 39,956
Purchases of property, plant and equipment 8,400 5,115
Depreciation and amortization 13,376 12,133
Assets 426,406 366,518
Equity investment in joint venture 9,886 10,433
Salt Life Group [Member]    
Net sales 60,060 49,735
Salt Life Group [Member] | Operating Segments [Member]    
Net sales 60,060 49,735
Operating income [2] 8,187 5,793
Purchases of property, plant and equipment 3,978 471
Depreciation and amortization 1,656 1,621
Assets 90,580 63,184
Equity investment in joint venture $ 0 $ 0
[1] In 2020, the Delta Group operating income included $23.7 million of expenses related to the COVID-19 pandemic. These costs primarily related to the curtailment of manufacturing operations ($11.9 million), incremental costs to right size production to new forecasted demand ($2.6 million), increased accounts receivable and inventory reserves related to the heightened risks in the market as the U.S. continues its recovery ($6.3 million), and other expenses ($2.9 million). These costs are included within net sales ($0.4 million), cost of goods sold ($14.2 million), SG&A expenses ($1.1 million), and other loss (income), net ($8.0 million).
[2] In 2020, the Salt Life Group operating income included approximately $0.3 million of increased accounts receivable and inventory reserves related to the heightened risks in the market as the U.S. continues its recovery from the COVID-19 pandemic, as well as $0.5 million of other expenses. These costs are included within net sales ($0.1 million), SG&A expenses ($0.6 million), and other loss (income), net ($0.1 million).